Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28473558 | 0.97 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL13051348 | 0.85 | ALDH1A1 (0.39) | ALDH1A1TSHRFFAR3TDP1GAA | |
| SCHEMBL580509 | 0.85 | TSHR (0.44) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL8187643 | 0.81 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL27984219 | 0.79 | ALDH1A1 (0.35) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL16583132 | 0.78 | TSHR (0.38) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL8600530 | 0.77 | AKR1B1 (0.37) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL6273792 | 0.77 | TSHR (0.33) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL3470836 | 0.76 | TSHR (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL11359551 | 0.76 | FFAR3 (0.38) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020026143-A1 | PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2020-02-06 | — | — | WO | claimed |
| US-20200040108-A1 | PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA | 2020-02-06 | — | — | US | claimed |
| EP-3604346-A1 | PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES | Procter & Gamble International Operations SA (CH) | 2020-02-05 | — | — | EP | claimed |
| US-10189015-B2 | Hydroprocessing catalyst composition containing an acetoacetic acid compound, a method of making such a catalyst, and a process of using such catalyst | SHELL OIL COMPANY (US) | 2019-01-29 | — | — | US | claimed |
| EP-3209752-A1 | A HYDROPROCESSING CATALYST COMPOSITION CONTAINING AN ACETOACETIC ACID COMPOUND, A METHOD OF MAKING SUCH A CATALYST, AND A PROCESS OF USING SUCH CATALYST CATALYST | Shell Internationale Research Maatschappij B.V. (NL) | 2017-08-30 | — | — | EP | claimed |
| US-20160152825-A1 | PROCESS FOR PRODUCING COMPOSITES | EVONIK DEGUSSA GMBH (DE) | 2016-06-02 | — | — | US | claimed |
| EP-3026072-A1 | Method for the preparation of composites | Evonik Degussa GmbH (DE) | 2016-06-01 | — | — | EP | claimed |
| US-20160114315-A1 | HYDROPROCESSING CATALYST COMPOSITION CONTAINING AN ACETOACETIC ACID COMPOUND, A METHOD OF MAKING SUCH A CATALYST, AND A PROCESS OF USING SUCH CATALYST | SHELL USA, INC. | 2016-04-28 | — | — | US | claimed |
| US-9117962-B2 | CIGS light-absorbing ink and method for preparing CIGS light-absorbing layer | GS CALTEX CORPORATION (KR) | 2015-08-25 | — | — | US | claimed |
| US-20150132885-A1 | CIGS LIGHT-ABSORBING INK AND METHOD FOR PREPARING CIGS LIGHT-ABSORBING LAYER | GS CALTEX CORPORATION (KR) | 2015-05-14 | — | — | US | claimed |
| US-20150125989-A1 | METHOD FOR PREPARING LIGHT-ABSORBING LAYER FOR CIS- OR CIGS-BASED SOLAR CELLS, AND LIGHT-ABSORBING INK FOR CIS- OR CIGS-BASED SOLAR CELLS | GS CALTEX CORPORATION (KR) | 2015-05-07 | — | — | US | claimed |
| WO-2008072257-A2 | PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES | IND-SWIFT LABORATORIES LIMITED (IN) | 2008-06-19 | — | — | WO | claimed |
| EP-0912467-B1 | ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE | RHODIA CHIMIE SA (FR) | 2002-04-24 | — | — | EP | claimed |
| EP-0900214-B1 | PROCESS FOR PREPARATION OF PYRIMIDINE DERIVATIVES | YUHAN CORP (KR) | 2001-09-26 | — | — | EP | claimed |
| EP-0226558-B1 | Chemical intermediates and methods for their preparation | HAESSLE AB (SE) | 1994-04-06 | — | — | EP | claimed |
| JP-54130598-A | — | — | None | — | — | JP | disclosed |
| US-12559457-B2 | Sulfonamide derivatives for protein degradation | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-4291036-A | Pyrido[1,2-A]pyrimidine derivatives and method of analgesic treatment | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1981-09-22 | — | — | US | disclosed |
| US-4219649-A | ANALGESICS | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT (HU) | 1980-08-26 | — | — | US | disclosed |
| JP-S54130598-A | PREPARATION OF 1,2-DIHYDRO-3H-PYRROLO3,2-EINDOLE DERIVATIVE | MITSUI TOATSU CHEM INC | 1979-10-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559457-B2 | Sulfonamide derivatives for protein degradation | CRBN, ADRM1, RBX1 | ALDH1A1 3921/4885TSHR 1520/4885CYP2D6 4676/4885 |
| US-20200040108-A1 | PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES | MGAM, FUT5, FUT6 | ALDH1A1 464/4885TSHR 1930/4885CYP2D6 1424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.